Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



A Phase 2 Pilot Study of ADP-A2M4 in Combination with Pembrolizumab in Subjects with Recurrent or Metastatic Head and Neck Cancer

Head/Neck

Head/Neck
II
Gibson, Mike
NCT04408898
VICCHN2034


Spearhead 1 Study in Subjects With Advanced Synovial Sarcoma or Myxoid / Round Cell Liposarcoma

Sarcoma

This is a study of genetically engineered ADP-A2M4 in HLA-A*02 subjects with metastatic or inoperable (advanced) Synovial Sarcoma or MRCLS who have received prior chemotherapy and whose tumor expresses the MAGE-A4 tumor antigen.
Sarcoma
II
Keedy, Vicki
NCT04044768
VICCSAR1948

Study Evaluating Brexucabtagene Autoleucel (KTE-X19) in Pediatric and Adolescent Participants With Relapsed / Refractory B-precursor Acute Lymphoblastic Leukemia or Relapsed / Refractory B-Cell Non-Hodgkin Lymphoma

Pediatric Leukemia

The primary objectives of this study are to evaluate the safety and efficacy of brexucabtagene autoleucel (KTE-X19) in pediatric and adolescent participants with relapsed / refractory (r / r) B-precursor acute lymphoblastic leukemia (ALL) or relapsed or refractory (r / r) B-cell non-Hodgkin lymphoma (NHL).
Pediatric Leukemia
I/II
Kitko, Carrie
NCT02625480
VICCPED15143

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: